These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6305599)

  • 1. Antibody to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma.
    Chen JY; Liu MY; Lynn TC; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Nov; 15(4):255-61. PubMed ID: 6305599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to Epstein-Barr virus specific DNase in sera of nasopharyngeal carcinoma and other nine most common cancer patients in Taiwan.
    Hsu MM; Chen JY; Liu MY; Lynn TC; Tu SM; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug; 17(3):131-7. PubMed ID: 6096088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study.
    Chen JY; Hwang LY; Beasley RP; Chien CS; Yang CS
    J Med Virol; 1985 Jun; 16(2):99-105. PubMed ID: 2989423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma.
    Chen JY; Liu MY; Chen CJ; Hsu MM; Tu SM; Lee HH; Kuo SL; Yang CS
    J Med Virol; 1985 Sep; 17(1):47-9. PubMed ID: 2995572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC; Chen JY; Glaser R; Henle W
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan.
    Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Beasley RP; Hwang LY
    J Med Virol; 1989 Apr; 27(4):269-73. PubMed ID: 2542436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups.
    Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Lee HH; Kuo SL
    J Med Virol; 1987 Sep; 23(1):11-21. PubMed ID: 2824675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
    Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
    Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
    Bardy B; Morinet F; Pérol Y
    Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to Epstein-Barr virus-specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma.
    Tan RS; Cheng YC; Naegele RF; Henle W; Glaser R; Champion J
    Int J Cancer; 1982 Nov; 30(5):561-5. PubMed ID: 6295964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal carcinoma and Epstein-Barr virus--associated serologic markers.
    Tam JS; Murray HG
    Ear Nose Throat J; 1990 Apr; 69(4):261-7. PubMed ID: 2161732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells.
    Sbih-Lammali F; Berger F; Busson P; Ooka T
    Virology; 1996 Aug; 222(1):64-74. PubMed ID: 8806488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified recombinant EBV desoxyribonuclease in serological diagnosis of nasopharyngeal carcinoma.
    Stolzenberg MC; Debouze S; Ng M; Sham J; Choy D; Bouguermouh A; Chan KH; Ooka T
    Int J Cancer; 1996 May; 66(3):337-41. PubMed ID: 8621254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
    Hsu MM; Chen JY; Chen CJ
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):984-8. PubMed ID: 2853721
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
    J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
    Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS
    J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma.
    Liu MY; Chou WH; Nutter L; Hsu MM; Chen JY; Yang CS
    J Med Virol; 1989 Jun; 28(2):101-5. PubMed ID: 2544674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.